Sichuan Yuxin Pharmaceutical Co., Ltd. Active Pharmaceutical Ingredient Production Line Expansion Project

First Public Notice for Public Participation in the Environmental Impact Assessment

Attachment 1: Public Opinion Form for the Environmental Impact Assessment of the Chemical Synthesis API Production Line Project, Sichuan Yuxin Pharmaceutical Co., Ltd. docx

I. Project Name and Overview

1. Project Name: Sichuan Yuxin Pharmaceutical Co., Ltd.

2. Project Type: Expansion

3. Construction Address: No. 51, West Section of Jialingjiang Road, Economic Development Zone (South Area), Shifang City

4. Construction Scope and Scale: Lease the factory buildings, R&D facilities, and supporting infrastructure of Shifang Ousai Biological Technology Co., Ltd., with a total floor area of 21,000 square meters. Utilize the existing production workshops of Ousai Biological Technology Co., Ltd. to expand four active pharmaceutical ingredient (API) production lines, including: Lidocaine Hydrochloride, Dehydrocholesterol, Furosemide, and Diphenhydramine Hydrochloride lines. Upon completion, the project will achieve an annual production capacity of 20 tons of other anesthetic drugs, 4 tons of other vitamins and their derivatives, 2.5 tons of other cardiovascular system medications, and 2.5 tons of antihistamine drugs.

5. Total project investment: 40 million yuan.

6. Existing Projects and Their Environmental Protection Status

According to the investigation, the off-site relocation project of Sichuan Yuxin Pharmaceutical Co., Ltd. completed its environmental protection acceptance inspection in January 2019. Therefore, the current status of the project and its environmental protection measures are as follows:

Construction scope: The project includes the construction of a comprehensive extraction workshop No. 1, a synthesis workshop, a traditional Chinese medicine slice workshop, and other supporting facilities. Currently, within the existing production area, there is one 80 t/a baicalin production line, one 150 t/a berberine hydrochloride production line, one 80 t/a rutin production line, one 10 t/a andrographolide production line, one 10 t/a puerarin production line, one 3 t/a vitamin D2 production line, one 3 t/a vitamin D3 production line, and one 50,000 t/a traditional Chinese medicine slice production line.

Environmental Protection Status:

1) Wastewater: Production wastewater from this project is first treated at the on-site wastewater treatment station, then combined with domestic sewage—pre-treated in a septic tank—and finally discharged into the urban sewage network, where it flows to the Shifang City Municipal Wastewater Treatment Plant for further processing.

2) Exhaust gases: Corresponding dust removal and purification equipment are provided for various types of exhaust gases, ensuring emissions meet regulatory standards.

3) Noise: Low-noise equipment was selected for the motors of all pumps and machinery, and various noise control measures were implemented, including vibration isolation and soundproofing, installation of sound enclosures, integration of silencers, use of vibration-damping bases, and acoustic insulation in building structures.

4) Solid Waste: After being collected and sorted, solid waste is disposed of in accordance with the "Three Transformations" principle.

II. Name and Contact Information of the Project Owner

1. Name of the Construction Entity: Sichuan Yuxin Pharmaceutical Co., Ltd.

2. Address: No. 51, West Section of Jialingjiang Road, South Area, Shifang Economic Development Zone

3. Contact: Mr. Ruan

4. Phone: 13981081596

5. Email: 2861718663@qq.com

III. Name and Contact Information of the Environmental Impact Assessment Agency

1. Evaluation Agency Name: Sichuan Huanke Yuan Technology Co., Ltd.

2. Address: Floor 12, Building B, Changhong Technology Tower, No. 199 Tianfu 4th Street, High-Tech Zone, Chengdu

3. Contact: Mr. Chen

4. Phone: 613-321-95

5. Email: 659317770@qq.com

4. Online Link to the Public Feedback Form

See the attachment

V. Main Ways for the Public to Submit Feedback

During the public consultation period, members of the public are invited to share their opinions and feedback on the project construction and the environmental impact assessment process by contacting the project proponent or the EIA agency via phone, mail, email, or other communication methods. To help us better understand your specific comments and suggestions, please provide detailed contact information when submitting your input.

This public notice is valid for 10 working days from the date of publication. Members of the public submitting comments are requested to include the date of submission, their full name, and contact information for timely feedback if needed.